AIMD Ainos, Inc.
Ainos, Inc., a dual-platform company, focusing artificial intelligencebased smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.…
Industry Peers
Scientific & Technical InstrumentsKey Statistics
About Ainos (NASDAQ: AIMD)
›
Ainos (NASDAQ: AIMD) is listed on Nasdaq, where its shares trade in USD. It belongs to the Scientific & Technical Instruments industry, part of the Technology sector, and reports about 41 employees.
The shares were at 1.180 USD on 20 November 2026, down 55.8% over 52 weeks. Its 52-week range is 0.4340 USD to 3.160 USD: the price is 62.7% below the high and 171.9% above the low.
Its market capitalisation is 8.93M USD.
Ainos reports return on equity of -195.3% and revenue down 96.7% year over year.
Its debt exceeds its cash by 12.39M USD, a debt-to-equity ratio of 1.45. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.